Cannabis may have serious interactions with some drugs. It is recommended that clinicians privilege non-interacting alternatives where clinically feasible. Examples of serious interactions with cannabis include:

• Warfarin: Smoked cannabis may inhibit the metabolism of warfarin (CYP2C9 substrate), resulting in increased international normalized ratio and risk of bleeding.
• Clopidogrel: Since cannabis inhibits CYP2C19, concomitant use leads to subtherapeutic concentrations of clopidogrel. This decreases its protective effects on cardiovascular disease and events.
• Clobazam: Increased risk of benzodiazepine toxicity.
• CNS depressants and sympathomimetics: Additive effects
• Theophylline, clozapine, and olanzapine: Reduced efficacy

 

Source: Download PDF [254 KB]

Content on this page has not been checked for accuracy. The author's credentials have not been confirmed. Always use multiple peer-reviewed scholarly sources and good clinical judgement in your decision making.

The Compendium platform was created by David Kwinter, MD, CCFP(EM).